Rezultati pretraživanja
  1. 1. velj
  2. 30. sij

    Michelle Keefe, President of Commercial Solutions at explores what the year has in store for >>

  3. 29. sij

    Pacylex- Data from four different preclinical models suggest that PCLX-001 has robust efficacy in leukemia and lymphoma

  4. 29. sij
  5. 29. sij

    The virtual liver will be the biotech breakthrough of the 2020s. Much like a real liver performing vital life functions but 100% scalable in the cloud.

  6. 29. sij

    Another interview is up! Hear Michelle Keefe, President of Commercial Solutions , explore what the drug industry should do to tell patient stories about positive therapeutic impact. Plus, her 2020 outlook & more!

  7. 28. sij

    Speaking at 2020, , of gives an update the company's progress with its investigational medicine, OV101 (gaboxadol) for the treatment of Angelman syndrome and Fragile X syndrome >>

  8. 27. sij

    Check out 's first interview with Dr. Jeremy Levin, Chairman & CEO . Dr. Levin discusses 2020 biotech investment, Ovid's progress with its investigational medicine for Angelman & Fragile X syndromes, & more!

  9. 27. sij

    Discover what leaders and experts in both biotech and finance had to say during the busiest week in healthcare while attending and >>

  10. 17. sij

    AgeX Therapeutics Presenting at Four Conferences this month: > , Jan 13-15 during > PMWC 2020 Jan 21-24 > World Stem Cell Summit Jan 21-24 > Therapeutics Jan 28-30

  11. 17. sij

    It was so incredible to hear about all of the new ways we can continue to advocate and educate for at this year's .

  12. 16. sij

    Thanks for inviting me and thank you to those who came to see us!

  13. 16. sij
  14. 16. sij

    The media roundup at is becoming a staple for winding down week. Great discussion w/ industry journalists

  15. 16. sij

    ”At Leaps we also consider venture investment to be a marathon, not a sprint. We strongly believe in 4-6 years as an investment horizon to advance true breakthroughs rather than quick wins“, said Juergen Eckhardt, Head of

  16. 16. sij

    Rounding up three exciting days of during with a panel discussing different issues and trends that unfolded during the week

    Prikaži ovu nit
  17. Sanjay Mistry highlights incubation model is no strings attached, offering mentorship, expertise, & a “community of companies” of shared learning among residents.

  18. Today at , top investors, including ’s , reflect on the excitement of investing vs the reality & challenges innovators face in bringing new medicines to patients.

  19. 15. sij

    . is one of the top funded universities in the world and at we are always looking to reinvent how we deliver care. So we are able to take the cutting edge of science and run it through our internal engine in order to spur growth.

  20. In step with the rapid transformation of startup business models, seed financing continues to evolve. Join Head Sanjay Mistry today to learn more about key changes that can impact life science innovators in 2020.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.